China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE: 000999)

China Resources Sanjiu Medical & Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5,482	6,771	3,150	3,065	3,824	3,091
Trading Asset Securities	3,285	1,456	-	1,219	200.18	-
Cash & Short-Term Investments	8,767	8,227	3,150	4,284	4,024	3,091
Cash Growth	28.91%	161.19%	-26.48%	6.45%	30.18%	24.84%
Accounts Receivable	8,233	7,946	5,644	5,419	4,807	4,897
Other Receivables	235.49	56.56	14.02	79.28	49.05	779.73
Receivables	8,469	8,003	5,658	5,498	4,856	6,022
Inventory	4,992	5,112	2,499	2,369	1,762	1,458
Other Current Assets	933.41	1,180	681.97	527.57	283.32	232.29
Total Current Assets	23,162	22,522	11,988	12,679	10,925	10,804
Property, Plant & Equipment	6,520	6,614	4,816	4,263	3,767	3,612
Long-Term Investments	692.55	643.12	2,913	238.69	176.35	821.82
Goodwill	5,124	5,124	3,995	4,060	4,105	3,354
Other Intangible Assets	3,400	3,457	2,369	2,297	2,178	1,812
Long-Term Deferred Tax Assets	590.89	626.81	324.5	242.1	150.3	125.82
Long-Term Deferred Charges	805.35	788.34	509.29	467.08	522.68	383.62
Other Long-Term Assets	403.76	373.28	207.33	295.37	185.78	488.78
Total Assets	40,698	40,148	27,123	24,542	22,010	21,402
Accounts Payable	3,098	3,097	1,795	1,499	1,118	1,048
Accrued Expenses	1,153	4,569	3,666	3,215	3,547	3,529
Short-Term Debt	905.52	885.65	168.5	90.04	25	30
Current Portion of Long-Term Debt	344.52	93.42	10.76	-	-	-
Current Portion of Leases	-	78.6	50.12	45.47	-	-
Current Income Taxes Payable	555.27	254.47	110.6	168.15	181.61	110.63
Current Unearned Revenue	1,474	1,650	1,012	1,476	980.14	797.86
Other Current Liabilities	5,048	2,318	1,859	1,453	1,444	1,385
Total Current Liabilities	12,578	12,947	8,673	7,947	7,295	6,899
Long-Term Debt	1,645	1,821	50.22	7.97	-	895.78
Long-Term Leases	95.31	119.51	105.82	88.71	-	-
Long-Term Unearned Revenue	464.49	455.5	423.19	395.13	346.4	355.35
Long-Term Deferred Tax Liabilities	339.65	340.79	217.75	198.88	195.42	140.59
Other Long-Term Liabilities	202.48	114.64	36.8	40.19	113.81	32.52
Total Liabilities	15,324	15,887	9,589	8,767	7,951	8,324
Common Stock	1,285	988.18	988.35	978.9	978.9	978.9
Additional Paid-In Capital	1,608	1,878	1,797	1,644	1,636	1,844
Retained Earnings	17,078	16,162	14,297	12,690	11,117	9,941
Treasury Stock	-87.84	-131.98	-143.57	-	-	-
Comprensive Income & Other	71.3	71.26	70.59	0.22	-4.96	-3.55
Total Common Equity	19,954	18,967	17,010	15,313	13,727	12,760
Minority Interest	5,420	5,295	523.78	461.28	331.95	318.03
Shareholders' Equity	25,374	24,262	17,533	15,774	14,059	13,078
Total Liabilities & Equity	40,698	40,148	27,123	24,542	22,010	21,402
Total Debt	2,990	2,998	385.42	232.18	25	925.78
Net Cash (Debt)	5,777	5,229	2,764	4,052	3,999	2,166
Net Cash Growth	71.19%	89.15%	-31.78%	1.31%	84.68%	11.57%
Net Cash Per Share	4.51	4.09	2.15	3.18	3.14	1.70
Filing Date Shares Outstanding	1,290	1,285	1,285	1,273	1,273	1,273
Total Common Shares Outstanding	1,290	1,285	1,285	1,273	1,273	1,273
Working Capital	10,584	9,575	3,316	4,732	3,630	3,905
Book Value Per Share	15.47	14.76	13.24	12.03	10.79	10.03
Tangible Book Value	11,430	10,387	10,645	8,956	7,445	7,595
Tangible Book Value Per Share	8.86	8.09	8.29	7.04	5.85	5.97
Buildings	-	5,122	3,459	3,419	3,170	2,971
Machinery	-	4,544	3,621	3,361	3,053	2,842
Construction In Progress	-	537.8	946.09	407.7	287.54	390.3

Source: S&P Capital IQ. Standard template. Financial Sources.